AMLX
Price
$3.51
Change
-$0.27 (-7.14%)
Updated
Apr 3 closing price
Capitalization
310.99M
34 days until earnings call
LSTA
Price
$2.10
Change
+$0.03 (+1.45%)
Updated
Apr 3 closing price
Capitalization
17.84M
33 days until earnings call
Ad is loading...

AMLX vs LSTA

Header iconAMLX vs LSTA Comparison
Open Charts AMLX vs LSTABanner chart's image
Amylyx Pharmaceuticals
Price$3.51
Change-$0.27 (-7.14%)
Volume$721.36K
Capitalization310.99M
Lisata Therapeutics
Price$2.10
Change+$0.03 (+1.45%)
Volume$12.08K
Capitalization17.84M
AMLX vs LSTA Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. LSTA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a StrongBuy and LSTA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AMLX: $3.51 vs. LSTA: $2.16)
Brand notoriety: AMLX and LSTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 91% vs. LSTA: 76%
Market capitalization -- AMLX: $310.99M vs. LSTA: $17.84M
AMLX [@Biotechnology] is valued at $310.99M. LSTA’s [@Biotechnology] market capitalization is $17.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileLSTA’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • LSTA’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than LSTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 6 TA indicator(s) are bullish while LSTA’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 6 bullish, 2 bearish.
  • LSTA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than LSTA.

Price Growth

AMLX (@Biotechnology) experienced а -9.30% price change this week, while LSTA (@Biotechnology) price change was -10.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

AMLX is expected to report earnings on May 08, 2025.

LSTA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($311M) has a higher market cap than LSTA($17.8M). AMLX YTD gains are higher at: -7.143 vs. LSTA (-29.530). LSTA has higher annual earnings (EBITDA): -22.24M vs. AMLX (-290.98M). AMLX has more cash in the bank: 177M vs. LSTA (31.2M). LSTA has less debt than AMLX: LSTA (137K) vs AMLX (1.98M). AMLX has higher revenues than LSTA: AMLX (87.4M) vs LSTA (1M).
AMLXLSTAAMLX / LSTA
Capitalization311M17.8M1,747%
EBITDA-290.98M-22.24M1,309%
Gain YTD-7.143-29.53024%
P/E Ratio2.69N/A-
Revenue87.4M1M8,740%
Total Cash177M31.2M567%
Total Debt1.98M137K1,446%
FUNDAMENTALS RATINGS
LSTA: Fundamental Ratings
LSTA
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXLSTA
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 22 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PINE16.49-0.24
-1.43%
Alpine Income Property Trust
PAGP20.65-0.96
-4.44%
Plains GP Holdings LP
ARE86.25-6.08
-6.59%
Alexandria Real Estate Equities
BIVI0.88-0.08
-7.88%
BioVie Inc
SABR2.34-0.35
-13.01%
Sabre Corp

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-7.14%
XOMAO - AMLX
68%
Closely correlated
+1.46%
IKNA - AMLX
54%
Loosely correlated
-4.00%
XOMAP - AMLX
51%
Loosely correlated
+0.90%
JAZZ - AMLX
43%
Loosely correlated
-4.44%
RGNX - AMLX
43%
Loosely correlated
-5.39%
More

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and RAIN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RAIN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
+1.45%
RAIN - LSTA
29%
Poorly correlated
+6.22%
HEPA - LSTA
26%
Poorly correlated
+1.21%
ASND - LSTA
26%
Poorly correlated
-1.35%
MRUS - LSTA
25%
Poorly correlated
-2.98%
AMLX - LSTA
25%
Poorly correlated
-7.14%
More